PAPER Winblad B, Kivipelto M, Andersen P, Johansson G, Andreasen N
SEARCH RESULTS
329960 RESULTS
PAPER Brown LA, Jin J, Ferrell D, Sadic E, Obregon D, Smith AJ, Tan J, Giunta B
Efavirenz promotes β-secretase expression and increased Aβ1-40,42 via oxidative stress and reduced microglial phagocytosis: implications for HIV associated neurocognitive disorders (HAND).
PLoS One. 2014;9(4):e95500. Epub 2014 Apr 23 PubMed: 24759994PAPER Liu MX, Liu JG, Li H
[Chinese materia medica monomers and components research progress on treating Alzheimer's disease by targeting gamma-secretase].
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014 Mar;34(3):376-9. PubMed: 24758094PAPER Jung Y, Dickson DW, Murray ME, Whitwell JL, Knopman DS, Boeve BF, Jack CR Jr, Parisi JE, Petersen RC, Josephs KA
TDP-43 in Alzheimer's disease is not associated with clinical FTLD or Parkinsonism.
J Neurol. 2014 Jul;261(7):1344-8. Epub 2014 Apr 24 PubMed: 24760339PAPER Woodling NS, Wang Q, Priyam PG, Larkin P, Shi J, Johansson JU, Zagol-Ikapitte I, Boutaud O, Andreasson KI
Suppression of Alzheimer-associated inflammation by microglial prostaglandin-E2 EP4 receptor signaling.
J Neurosci. 2014 Apr 23;34(17):5882-94. PubMed: 24760848PAPER Parra-Damas A, Valero J, Chen M, España J, Martín E, Ferrer I, Rodríguez-Alvarez J, Saura CA
Crtc1 activates a transcriptional program deregulated at early Alzheimer's disease-related stages.
J Neurosci. 2014 Apr 23;34(17):5776-87. PubMed: 24760838PAPER Guo Y, Zhang Z, Zhou B, Wang P, Yao H, Yuan M, An N, Dai H, Wang L, Zhang X, Liu Y
Grey-matter volume as a potential feature for the classification of Alzheimer's disease and mild cognitive impairment: an exploratory study.
Neurosci Bull. 2014 Jun;30(3):477-89. Epub 2014 Apr 23 PubMed: 24760581PAPER Neumann B, Yarman A, Wollenberger U, Scheller F
Characterization of the enhanced peroxidatic activity of amyloid β peptide-hemin complexes towards neurotransmitters.
Anal Bioanal Chem. 2014 May;406(14):3359-64. Epub 2014 Apr 24 PubMed: 24760399PAPER Relkin N
Clinical trials of intravenous immunoglobulin for Alzheimer's disease.
J Clin Immunol. 2014 Jul;34 Suppl 1:S74-9. Epub 2014 Apr 24 PubMed: 24760112PAPER Counts SE, Ray B, Mufson EJ, Perez SE, He B, Lahiri DK
Intravenous immunoglobulin (IVIG) treatment exerts antioxidant and neuropreservatory effects in preclinical models of Alzheimer's disease.
J Clin Immunol. 2014 Jul;34 Suppl 1:S80-5. Epub 2014 Apr 24 PubMed: 24760109PAPER Verdan C, Casarsa D, Perrout MR, Santos M, Alves de Souza J, Nascimento O, Freire Coutinho ES, Laks J
Lower mortality rate in people with dementia is associated with better cognitive and functional performance in an outpatient cohort.
Arq Neuropsiquiatr. 2014 Apr;72(4):278-82. PubMed: 24760091PAPER Wajman JR, Oliveira FF, Schultz RR, Marin Sd, Bertolucci PH
Educational bias in the assessment of severe dementia: Brazilian cutoffs for severe Mini-Mental State Examination.
Arq Neuropsiquiatr. 2014 Apr;72(4):273-7. PubMed: 24760090PAPER Walsh KP, Minamide LS, Kane SJ, Shaw AE, Brown DR, Pulford B, Zabel MD, Lambeth JD, Kuhn TB, Bamburg JR
Amyloid-β and proinflammatory cytokines utilize a prion protein-dependent pathway to activate NADPH oxidase and induce cofilin-actin rods in hippocampal neurons.
PLoS One. 2014;9(4):e95995. Epub 2014 Apr 23 PubMed: 24760020PAPER Lee SH, Kim Y, Kim HY, Kim YH, Kim MS, Kong JY, Lee MH, Kim DJ, Ahn YG
Aminostyrylbenzofuran directly reduces oligomeric amyloid-β and reverses cognitive deficits in Alzheimer transgenic mice.
PLoS One. 2014;9(4):e95733. Epub 2014 Apr 23 PubMed: 24760018PAPER Yuzwa SA, Vocadlo DJ
O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond.
Chem Soc Rev. 2014 Oct 7;43(19):6839-58. Epub 2014 Apr 24 PubMed: 24759912Current Filters
No filters selected